- Rating
- 1
- Confidence
- 4
- Informativeness
- 2
- Presentation
- 2
- Soundness
- 2
Read review
Paper summary
This paper proposes Hierarchical-Restoring Adaptation and Correction (HRAC) for source-free test-time adaptation in brain tumor segmentation under changes in image appearance and tumor composition. HRAC comprises two stages. Structure-Consistency Adaptation (SCA) updates BatchNorm affine parameters using flip consistency and a partial-order consistency loss defined over the nested enhancing tumor (ET), tumor core (TC), and whole tumor (WT) regions. Hierarchical Label Shift Correction (HLSC) subsequently applies per-volume additive logit biases based on violations of fixed bounds on intra-tumor composition ratios, without explicitly estimating the target class prior. The main evaluation transfers a model trained on BraTS 2023 adult glioma to three pediatric or Sub-Saharan African cohorts, comparing against seven adaptation/correction methods. HRAC achieves the best reported mean Dice, HD95, and IoU across these targets.
Critical strengths
-
The paper attempts to address a meaningful limitation of deploying adult-trained segmentation models on populations with different tumor compositions.
-
HRAC improves computational efficiency by restricting optimization to BatchNorm affine parameters, requiring only two adaptation steps per volume, and applying the final correction without gradient-based optimization.
-
The SCA component achieves a large performance gains across all three segmentation targets.
Critical weaknesses
-
Insufficient justification of the thresholds. The choice of the structural composition prior (0.4, 0.6, 0.6) lacks a clear derivation or supporting references.
-
The SCA component contributes the largest performance gain. However, enforcing consistency between original and augmented views is a common strategy in TTA methods, and the manuscript does not sufficiently clarify the novelty of SCA relative to existing approaches.
-
Limited and uneven benefits of HLSC. Despite being a central contribution, HLSC consistently reduces WT and ET Dice in Tables 2 and 3, while yielding only marginal gains in mean Dice.
-
Limited comparisons with recent methods. The evaluation does not include any methods proposed in 2026, making it difficult to assess HRAC’s competitiveness against recent advances in TTA.
-
Please include comparisons with additional medical TTA methods, particularly GraTa [1], which is also designed for medical image segmentation and employs a consistency constraint between original and augmented views. [1] Chen Z, Ye Y, Pan Y, et al. Gradient alignment improves test-time adaptation for medical image segmentation[C]//Proceedings of the AAAI Conference on Artificial Intelligence. 2025, 39(3): 2429-2437.
Questions for authors
-
How were the thresholds (0.4, 0.6, and 0.6) selected, and what empirical evidence supports their validity?
-
How does SCA differ from existing TTA methods that enforce consistency between original and augmented views?
-
Why does HLSC consistently lead to lower performance for WT and ET?
-
Could the authors include comparisons with more recent medical TTA methods published in 2026, or clarify why these methods were omitted?
3 comments
Thank you for the detailed response and additional experiments. My main concerns remain. For example, the explanation of SCA clarifies the intended role of flip consistency and the partial-order term, but it does not yet establish which part of the gain comes from their proposed interaction, as opposed to established consistency-based adaptation. A controlled comparison isolating that interaction would make the novelty claim more convincing. Overall, the rebuttal addresses some of my questions, but the remaining concerns do not change my assessment. I will maintain my original rating.
Response to Reviewer Yniy
We thank you for the continued engagement. To clarify the controlled comparison you requested, we have assembled a decomposition from the ablation tables, paired statistics, and a new controlled run.
As summarized below, the first table shows the cumulative gain of adding one component at a time, while the second table presents the ablation results where the partial-order term is replaced by the established entropy minimization
Table 1. Cumulative module addition
| Configuration (Base: Source model) | Mean Dice | Δ |
|---|---|---|
| Source model | 50.81 | — |
| + Flip consistency | 59.66 | +8.85 (vs. Source) |
| + Poset (SCA) | 60.43 | +0.77 (vs. +Flip) |
| + HLSC (HRAC) [Proposed] | 61.49 | +1.05 (vs. SCA) |
Table 2. Controlled comparison (Entropy replacement)
| Configuration (Base: Source model) | Mean Dice | Δ |
|---|---|---|
| Source model | 50.81 | — |
| + Flip + Entropy (no HLSC) | 59.60 | −0.83 (vs. SCA) |
| + Flip + Entropy + HLSC | 60.78 | −0.71 (vs. HRAC) |
We state plainly that flip consistency alone (the established component) accounts for 8.85 of the 9.62-point improvement over the unadapted baseline. However, neither the partial-order term alone (59.37) nor HLSC alone (51.87) recovers the full result.
Entropy minimization does not extend the established component (59.60 vs. 59.66). The partial-order term outperforms it by 1.36 in TC Dice , with identical WT. The critical difference lies in where the penalty is applied. The partial-order term penalizes only responses outside the tumor body, whereas entropy minimization sharpens every uncertain voxel, including correct ones inside the core. These outside responses are exactly the failure mode that consistency regularization fails to address. The same replacement inside the full pipeline yields the same conclusion (60.78 vs. 61.49).
The specific contribution of HLSC is evident in the TC region, which is exactly where the population shift distorts class composition. Adding HLSC improves the TC Dice by 7.78 and the mean HD95 by 15.62 mm.
Therefore, our novelty claim rests not on the consistency component itself, but on the structural constraints (SCA and HLSC), which repair the specific failure mode that established consistency-based adaptation cannot. We will incorporate this controlled decomposition explicitly into the revised manuscript so the source of the gain is verifiable at a glance.
We respectfully ask you to reconsider the novelty assessment in light of this evidence, and we hope this clarification is useful to the AC as well.
Response to Reviewer Yniy (1/1)
We greatly appreciate your constructive and insightful comments. We address all weaknesses below and will incorporate the corresponding changes into the revised manuscript.
W1&Q1: Insufficient justification of the thresholds.
The three values have a clear empirical basis, but they are used as one-sided structural bounds rather than as estimates of the target composition, so no derivation to an exact value is required.
(1) What the three values are. ρ_TC = 0.4 is a floor on the core share of the whole tumor, ρ_ED = 0.6 is a ceiling on the edema share, and ρ_ET = 0.6 is a floor on the ET share of the tumor core. The measured ratios are rTC=PTC/PWT, rED=PED/PWT, and rET=PET/PTC. Fig. 1(a) shows that in adult glioma the core makes up about four tenths of the whole tumor, edema about six tenths, and ET about six tenths of the core. Taking these proportions to one decimal place gives (0.4, 0.6, 0.6). They are coarse prior knowledge about typical composition rather than statistics estimated from source training labels. They are fixed before deployment, and adaptation accesses neither source data nor target labels, so the source-free setting is preserved.
(2) Why exact values are unnecessary. The constraints are one-sided. The bound decides whether a direction needs correction and the measured deviation decides by how much. The correction is zero when no bound is crossed, so a bound only needs the right scale and direction rather than an exact match to the typical composition of any cohort. We treat 0.4 as a loose floor that fires only when the core is clearly under-predicted.
(3) Experimental verification. A 7 × 7 × 7 sweep of ρ_s across the three dimensions (343 configurations, Appendix C.2 and Figure 4) changes Mean Dice only between 60.19 and 61.93, with every configuration within 0.90 points of the deployed one. The same bounds are shared across BraTS 2023 PED, BraTS 2025 PED and SSA without per-population adjustment, and HRAC achieves the best mean Dice and the best mean HD95 on all three (Table 1). What the method relies on is the directional constraint of the bounds, not any precise threshold.
W2&Q2: The novelty of SCA relative to view-consistency methods.
The difference between SCA and existing consistency methods lies in what the consistency is used for. In existing methods it serves as a smoothing regularizer or, as in GraTa, as the pseudo gradient, with the entropy loss supplying the auxiliary one for alignment. In SCA the flip runs first, making the prediction more confident and structurally self-consistent, so that a disagreement with its mirrored copy reflects a misplaced structure rather than noise. On top of that confident prediction the poset term takes over and suppresses the responses still falling outside the tumor body. What SCA recovers is where the structure sits and how far it extends, not a smoother probability map.
W3&Q3: Why do WT and ET decrease?
The gain of HLSC concentrates on TC, and it is large. Adding HLSC on top of SCA gains 7.78 in TC Dice, together with 1.05 in mean Dice and 15.62 mm in HD95. TC is exactly where the population shift acts and the weakest region for the source model (32.88 Dice).
The WT and ET decreases are the price of this concentration, and neither indicates a failure of the correction. The WT decrease is slight. WT always equals TC plus ED, and rTC+rED≡1 holds in all cases. Reallocation between core and edema does not change total foreground volume, so the correction leaves WT nearly in place, and with the source WT already close to GT, there is little room to gain. The ET decrease is a side effect of the TC correction, not the objective of the ET term. The correction uses rET=PET/PTC, whose denominator is the inflated TC, and raising NCR compresses rET, which triggers the ET term and raises ET predictions. Experimentally, the resulting false positives arise almost exclusively in cases that should contain no ET.
W4-5&Q4:Comparison with recent methods.
GraTa[1] and LATTA[2] have been added, reproduced under our protocol, and compared on BraTS 2023 PED. With the most recent 2025 and 2026 methods included, HRAC still leads in mean Dice and HD95.
[1] Chen Z, Ye Y, Pan Y, et al. Gradient alignment improves test-time adaptation for medical image segmentation. AAAI 2025.
[2] Weerasinghe, Thilina, et al. Logit-Adjusted Test-Time Adaptation under Partial Class Imbalance. WACV 2026.